Skip to main navigation Skip to main content

OPEN ACCESS

- Current Issue
  
  Volume 31 Issue 4
  
  Ahead of Print
  
  Past Issues
  
  Editor-in-Chief : Won Kim
  
  Indexed In
  
  SCIE, MEDLINE, PubMed, PMC, and Scopus
Journal Insights
- 16.9
  
  Impact Factor
- 19.7
  
  Cite Score
- 7 days
  
  First Decision
- 4 days
  
  Publication after Acceptance
View all insights

Editor's Pick

Original Article

High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease
Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, et al. Clin Mol Hepatol 2025;31(3):796-809.

Ahead of Print

Hypothyroidism and liver-related events risk in patients with metabolic dysfunction-associated steatotic liver disease

Xinrui Jin, Sherlot Juan Song, Jimmy Che-To Lai, et al.
Engineered nutrient-stimulated hormonal multi-agonist for precision targeting of obesity and metabolic disorders

Yun Kyung Cho, Chang Hee Jung
Novel Biomarkers for Alcohol-Associated Liver Disease and Their Implications Across Clinical Settings

Kaanthi Rama, Vinay Jahagirdar, Francisco Idalsoaga, et al.

Current Issue

The Liver Week 2025 Highlights: Celebrating the 30th Anniversary of the Korean Association for the Study of the Liver
Young Eun Chon, Ju Hyun Shim, Joo Hyun Oh, et al. Clin Mol Hepatol 2025;31(4):1107-1114.
Prospects of Mendelian randomization in hepatology: a comprehensive literature review with practice guidance
Lanlan Chen, Qi Rao, Menghan Gao, et al. Clin Mol Hepatol 2025;31(4):1115-1138.
Update in the treatment of cirrhotic patients with portal vein thrombosis
Jialin Wu, Xinyi Deng, Junyang Luo, et al. Clin Mol Hepatol 2025;31(4):1139-1166.

Guideline

KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025

Won Sohn, Young-Sun Lee, Soon Sun Kim, et al.
KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease

Mi Na Kim, Ji Won Han, Jihyun An, et al.
KASL clinical practice guidelines for management of autoimmune hepatitis 2022

The Korean Association for the Study of the Liver (KASL)

Video abstract

Non-contrast magnetic resonance imaging for detection of late recurrent hepatocellular carcinoma after curative treatment: a prospective multicenter comparison to contrast-enhanced computed tomography
Dong Wook Kim, Won Chang, So Yeon Kim, et al. Clin Mol Hepatol 2025;31(4):1285-1297.
Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
Hye Won Lee, Jae Seung Lee, Mi Na Kim, et al. Clin Mol Hepatol 2025;31(3):1018-1031.
Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
Tom Ryu, Young Chang, Soung Won Jeong, et al. Clin Mol Hepatol 2025;31(2):548-562.

Snapshot

Decoding platelet function in liver cirrhosis: A shift from quantity to quality

Vibhuti Jakhmola, Sukriti Baweja, Chhagan Bihari
Clin Mol Hepatol 2025;31(4):1384-1386.
Interventions targeting the gut-liver axis: A potential treatment strategy for metabolic dysfunction-associated steatotic liver disease

Pingping Jin, Xinyi Lu, Daozhen Chen, et al.
Clin Mol Hepatol 2025;31(3):1100-1102.
Modulation of lymphatic vessels in management of liver disease and complications

Aarti Sharma, Pinky Juneja, Shiv K Sarin, et al.
Clin Mol Hepatol 2025;31(2):665-668.

Most cited articles

Most viewed articles

Most downloaded articles